• A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

Carmustine Related Products


Carmustine is an alkylating agent used in the treatment of various malignancies, including brain tumours and multiple myeloma, among others  in the treatment of brain tumours the U.S. Food and Drug Administration (FDA) approved biodegradable discs infused with carmustine.


SynZeal is a leading innovator in pharmaceutical reference standards. We supply high-quality Reference Standards of Carmustine, pharmacopeial and non-pharmacopeial Carmustine impurities, metabolites, stable isotope products, and nitrosamines (N-NO products). Carmustine impurities reference standards are useful in pharmaceutical research. They are useful in product development, ANDA and DMF filing, quality control (QC), method validation, and stability studies. It is also useful in the identification of unknown impurities and the assessment of genotoxic potential.

Carmustine-related products are thoroughly characterized. Carmustine products are supplied with detailed COA & analytical data meeting regulatory compliance. We can also provide EP/USP traceable standards based on your requirements. The supplied products are re-tested at regular intervals.

Pharmaceutical Reference Standards

Carmustine

Picture of Carmustine
SZ CAT No:: SZ-C118001
CAS No: 154-93-8
Mol.F.: C5H9Cl2N3O2
Mol.Wt.: 214
Inv. Status: Custom Synthesis

Carmustine EP Impurity A

Picture of Carmustine EP Impurity A
SZ CAT No:: SZ-C118002
CAS No: 2214-72-4
Mol.F.: C5H10Cl2N2O
Mol.Wt.: 185
Inv. Status: Custom Synthesis

Carmustine EP Impurity B

Picture of Carmustine EP Impurity B
SZ CAT No:: SZ-C118003
CAS No: 689-98-5
Mol.F.: C2H6ClN
Mol.Wt.: 79.5
Inv. Status: Custom Synthesis

Carmustine Impurity 1

Picture of Carmustine Impurity 1
SZ CAT No:: SZ-C118004
CAS No: NA
Mol.F.: C6H9ClN2O3
Mol.Wt.: 192.6
Inv. Status: Custom Synthesis
Categories